title: Competitive electroporation formulation for cell therapy.
abstract: Established cell transfection via nucleofection relies on nucleofection buffers with unknown and proprietary makeup due to trade secrecy, inhibiting the possibility of using this otherwise effective method for developing cell therapy. We devised a three-step method for discovering an optimal formulation for the nucleofection of any cell line. These steps include the selection of the best nucleofection program and known buffer type, selection of the best polymer for boosting the transfection efficiency of the best buffer and the comparison with the optimal buffer from an established commercial vendor (Amaxa). Using this three-step selection system, competitive nucleofection formulations were discovered for multiple cell lines, which are equal to or surpass the efficiency of the Amaxa nucleofector solution in a variety of cells and cell lines, including primary adipose stem cells, muscle cells, tumor cells and immune cells. Through the use of scanning electron microscopy, we have revealed morphological changes, which predispose for the ability of these buffers to assist in transferring plasmid DNA into the nuclear space. Our formulation may greatly reduce the cost of electroporation study in laboratory and boosts the potential of application of electroporation-based cell therapies in clinical trials.
authors.affiliation: Department of Comparative Biomedical Sciences, Louisiana State University, Baton Rouge, USA.
authors.forename: M
authors.initials: M
authors.lastname: Flanagan
authors.forename: J M
authors.initials: JM
authors.lastname: Gimble
authors.forename: G
authors.initials: G
authors.lastname: Yu
authors.forename: X
authors.initials: X
authors.lastname: Wu
authors.forename: X
authors.initials: X
authors.lastname: Xia
authors.forename: J
authors.initials: J
authors.lastname: Hu
authors.forename: S
authors.initials: S
authors.lastname: Yao
authors.forename: S
authors.initials: S
authors.lastname: Li
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D064987:Cell- and Tissue-Based Therapy / Q000379:methods*; D018274:Electroporation / Q000379:methods*; D006367:HeLa Cells; D006801:Humans; D051379:Mice; D014162:Transfection